简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
512290.SH
Guotai CSI BIOMEDICINE ETF(512290) Rises 3.86% in Morning Trading, Sees Net Inflow of 42.1030 Million Yuan Over the Past 10 Trading Days
Tags:
ETF
512290.SH
Guotai CSI BIOMEDICINE ETF
2026-04-28
Guotai CSI BIOMEDICINE ETF(512290) Rises 0.91% Intraday,Institutions Confirm Clear Industry Recovery Trend
Tags:
ETF
Guotai CSI BIOMEDICINE ETF
512290.SH
2026-04-15
Institutions: Optimistic on Pharmaceutical Catalytic Opportunities,Guotai CSI BIOMEDICINE ETF(512290) Rises 3.86% Intraday
Tags:
ETF
Guotai CSI BIOMEDICINE ETF
512290.SH
2026-04-01
Guotai CSI BIOMEDICINE ETF(512290) Rises 1.19% Intraday,Cautious Optimism with Accelerated M&A Layout
Tags:
ETF
Guotai CSI BIOMEDICINE ETF
512290.SH
2026-02-10
Biomedical Industry Enters Innovation 3.0 Era,Guotai CSI BIOMEDICINE ETF (512290) Pulls Back 1.40%
Tags:
ETF
512290.SH
Biomedical ETF
2026-01-19
Featured News
Finance
China Longyuan Power (00916.HK): Implementation of 2025 Equity Distribution, Final Dividend of RMB 0.625 per 10 Shares
Finance
Shenwan Hongyuan (06806.HK): Subsidiary’s RMB 3.6 Billion Corporate Bonds Listed on Shenzhen Stock Exchange
Finance
New Focus (00360.HK): Appointment of Hord Capital as Independent Financial Adviser
Finance
China Everbright Greentech (01257.HK): Entered Framework Agreements for Hazardous Waste Disposal Services Covering 2026 to 2028
Finance
Muyuan Co., Ltd. (02714.HK): Completes Corporate Name Change
Finance
CGII HLDGS (01940.HK): Completion of Loan Assignment
Finance
Guofu Hydrogen Energy (02582.HK): H-share Full Circulation Granted Listing Approval by HKEX
Finance
Wise Wealth Resources Investment (00007.HK): Appointment of Hao Xiaohui as Executive Director and Co-Chairman, Xu Shiping Re-designated as Co-Chairman
Finance
Fosun Pharma (02196.HK): Controlled Subsidiary’s HLX3902 Injection Obtains Clinical Trial Approval
Finance
Xunhe Group (01591.HK): Expected Annual Loss to Widen to HK$13 Million – HK$16 Million
Scan QR Code
Download App